Patents by Inventor Chee M. Ng

Chee M. Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230212311
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Application
    Filed: June 15, 2022
    Publication date: July 6, 2023
    Applicant: Genentech, Inc.
    Inventors: DAVID E. ALLISON, RENE BRUNO, JIAN-FENG LU, CHEE M. NG
  • Publication number: 20200239595
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Application
    Filed: December 10, 2019
    Publication date: July 30, 2020
    Applicant: Genentech, Inc.
    Inventors: DAVID E. ALLISON, RENE BRUNO, JIAN-FENG LU, CHEE M. NG
  • Publication number: 20180327510
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Application
    Filed: March 2, 2018
    Publication date: November 15, 2018
    Applicant: Genentech, Inc.
    Inventors: DAVID E. ALLISON, RENE BRUNO, JIAN-FENG LU, CHEE M. NG
  • Publication number: 20170037147
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 9, 2017
    Applicant: Genentech, Inc.
    Inventors: David E. Allison, Rene Bruno, Jian-Feng Lu, Chee M. Ng
  • Publication number: 20150093381
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Application
    Filed: November 26, 2014
    Publication date: April 2, 2015
    Applicant: GENENTECH, INC.
    Inventors: David E. Allison, Rene Bruno, Jian-Feng Lu, Chee M. Ng
  • Patent number: 8404234
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: March 26, 2013
    Assignee: Genentech, Inc.
    Inventors: David E. Allison, Rene Bruno, Jian-Feng Lu, Chee M. Ng
  • Publication number: 20090081223
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Application
    Filed: October 9, 2008
    Publication date: March 26, 2009
    Applicant: Genentech, Inc.
    Inventors: David E. Allison, Rene Bruno, Jian-Feng Lu, Chee M. Ng
  • Patent number: 7449184
    Abstract: The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: November 11, 2008
    Assignee: Genentech, Inc.
    Inventors: David E. Allison, Rene Bruno, Jian-Feng Lu, Chee M. Ng